Long-term efficacy and safety of ocrelizumab in treatment-naive patients with early relapsing multiple sclerosis: 7-year data from the OPERA open-label extension trials

J. Cerqueira, A. Berthele, B. Cree, M. Filippi,G. Pardo,O. Pearson, A. Trabloulsee,T. Ziemssen, T. Vollmer,C. Bernasconi, C. Mandel, J. Overell, E. Havrdova

MULTIPLE SCLEROSIS JOURNAL(2022)

引用 0|浏览8
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要